Evidence map›Paper›PMID 37704633›Full record

ArticleScientific reports2023

Facile preparation of silver based radiosensitizers via biomineralization method for enhanced in vivo breast cancer radiotherapy.

Mohammadreza Ghaffarlou, Ali Mohammadi, Navid Mousazadeh, Marziyeh Salehiabar, Yahya Kalantari, Jalil Charmi, Murat Barsbay, Yavuz Nuri Ertas, Hossein Danafar, Hamed Rezaeejam and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Nanomedicine (London, England) · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Mohammadreza GhaffarlouDepartment of Chemistry, Hacettepe University, Beytepe, Ankara, 06800, Turkey.
Ali MohammadiZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Navid MousazadehZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Marziyeh SalehiabarZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Yahya KalantariZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Jalil CharmiZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Murat BarsbayDepartment of Chemistry, Hacettepe University, Beytepe, Ankara, 06800, Turkey.
Yavuz Nuri ErtasERNAM-Nanotechnology Research and Application Center, Erciyes University, Kayseri, 38039, Turkey.
Hossein DanafarZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Hamed RezaeejamDepartment of Radiology Technology, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, 45139-56184, Iran. hrezaeejam@yahoo.com.
Hamed NosratiZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran. Nosrati.hamed2020@gmail.com.
Siamak JavaniMedical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran. siamackjavani@yahoo.com.
Zanjan University of Medical Sciences · IRBiotechnology Research Center · IRHacettepe University · TRErciyes University · TRGolestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To solve the traditional radiotherapy obstacles, and also to enhance the radiation therapy efficacy various radiosensitizers have been developed. Radiosensitizers are promising agents that under X-ray irradiation enhance injury to tumor tissue by accelerating DNA damage. In this report, silver-silver sulfide nanoparticles (Ag-Ag

Indexed as

NeoplasmsRadiation OncologyRadiation-Sensitizing AgentsAnimalsBiomineralizationFolic AcidMiceResearch DesignSilverFolic AcidRadiation-Sensitizing AgentsSilver

Identifiers

PMID37704633
PMCPMC10499791
OpenAlexW4386712162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.